TAMMY SAULS: Open Payments
NPI 1104127661 · BECKLEY, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 41 payments from 9 companies in 2025. Trend: 2023 $648 · 2024 $602 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $232 |
| Janssen Pharmaceuticals, Inc | 7 | $133 |
| Alkermes, Inc. | 6 | $117 |
| ABBVIE INC. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: AUSTEDO XR, ARISTADA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY MAINTENA, FANAPT, SPRAVATO.
Industry payments across WV — which companies pay providers there.
